Instem
  • Products and Services3
    • In Silico & Data Insights3
      • Leadscope Model Applier
      • KnowledgeScan
      • Advance
      • Centrus®
    • Study Management3
      • Provantis
      • BioRails®
      • Logbook
      • NOTOCORD-hem
      • Morphit
    • Regulatory Submission3
      • SEND Advantage Services
      • Submit
    • Clinical Trial Analytics and Transparency3
      • Accel
      • Blur
      • Aspire
      • Clinical Trial Transparency (CTT) Services
  • About Us
  • Blog
  • Resources
  • Events
  • Customer Center3
    • Instem Customer Center
    • Perceptive Support
Contact Us
Instem
  • Products and Services3
    • In Silico & Data Insights3
      • Leadscope Model Applier
      • KnowledgeScan
      • Advance
      • Centrus®
    • Study Management3
      • Provantis
      • BioRails®
      • Logbook
      • NOTOCORD-hem
      • Morphit
    • Regulatory Submission3
      • SEND Advantage Services
      • Submit
    • Clinical Trial Analytics and Transparency3
      • Accel
      • Blur
      • Aspire
      • Clinical Trial Transparency (CTT) Services
  • About Us
  • Blog
  • Resources
  • Events
  • Customer Center3
    • Instem Customer Center
    • Perceptive Support
Contact Us
  • Products and Services3
    • In Silico & Data Insights3
      • Leadscope Model Applier
      • KnowledgeScan
      • Advance
      • Centrus®
    • Study Management3
      • Provantis
      • BioRails®
      • Logbook
      • NOTOCORD-hem
      • Morphit
    • Regulatory Submission3
      • SEND Advantage Services
      • Submit
    • Clinical Trial Analytics and Transparency3
      • Accel
      • Blur
      • Aspire
      • Clinical Trial Transparency (CTT) Services
  • About Us
  • Blog
  • Resources
  • Events
  • Customer Center3
    • Instem Customer Center
    • Perceptive Support
Contact Us
Instem Announces Acquisition of Trimetra Limited, Strengthening Preclinical R&D Solutions

Instem Announces Acquisition of Trimetra Limited, Strengthening Preclinical R&D Solutions

by Mike Thurogood, MCIM | Dec 23, 2024 | Press Releases

Instem is excited to announce that as of today it has closed on an acquisition of Trimetra. This acquisition aligns with our strategic vision of growth through organic and inorganic channels. Trimetra is a software development and consultancy business based in...
Meet the Experts at Instem—SEND Edition!

Meet the Experts at Instem—SEND Edition!

by Mike Thurogood, MCIM | Dec 5, 2024 | Regulatory Submission, SEND

Meet the Experts at Instem—SEND Edition! Welcome to “Meet the Experts,” a new series of articles focused on shining a spotlight on the brightest minds at Instem. This week’s topic is SEND, and the obvious choice for our expert is the esteemed Marc Ellison! Marc...
Next Entries »

SaaS Products & Services for R&D that drive discovery, accelerate studies and advance your research.

Contact Us

Products & Services

In Silico & Data Insights
Study Management
Regulatory Submission
Clinical Trial Analytics
View All Solutions

Useful Links

About Us
Blog
Customer Center
Contact Us

Legal Notice Privacy Policy Information Security Policy Environmental Policy Modern Slavery Policy Cookie Policy Recruitment Compliance Standards

  • 日本語
  • Deutsch
  • Français
  • 中文 (简体)